Exponent (EXPO) Receives a Rating Update from a Top Analyst


In a report released today, Joseph Foresi from Cantor Fitzgerald maintained a Buy rating on Exponent (EXPO), with a price target of $56. The company’s shares closed yesterday at $49.96.

Foresi commented:

“: We maintain our Overweight rating on Exponent and our PT of $56. We believe the nature of the company’s business gives Exponent an advantage in its ability to deliver results regardless of the economic backdrop. The company reported low-single-digit revenue growth for 4Q18, slightly below expectations. We expect revenues to grow in the mid-to-high single-digit range for all of 2019, with the opportunity for upside to conservative guidance, in our opinion, as we believe catalysts exist in a number of areas.”

According to TipRanks.com, Foresi is a top 25 analyst with an average return of 18.0% and a 76.4% success rate. Foresi covers the Technology sector, focusing on stocks such as Jack Henry & Associates, Fidelity National Info, and DXC Technology Company.

Exponent has an analyst consensus of Moderate Buy, with a price target consensus of $56.

See today’s analyst top recommended stocks >>

Exponent’s market cap is currently $2.6B and has a P/E ratio of 51.70. The company has a Price to Book ratio of 7.87.

Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of solutions. It operates through two segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides technical consulting in the areas of engineering and technology development.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts